Biotecnología
Biotecnología
Everads, Kriya Partner on Ocular Gene Therapy Candidates
28/09/2023 -
To use Everads' suprachoroidal delivery platform that enables non-surgical delivery to the back of the eye via the suprachoroidal space.
Charles River Launches Lentivation Gene Therapy Manufacturing Platform
27/09/2023 -
Aims to reduce LVV manufacturing timelines for gene and gene-modified cell therapies by up to 60 percent.
Porton Advanced, BRL Medicine Partner to Commercialize CGTs
19/09/2023 -
Alliance will enhance cell and gene therapy pipelines from BRL Medicine from clinical trials to further expedite commercialization of innovative therapies.
Fujifilm Diosynth Opens Viral Vector Gene Therapy Facility in UK
18/09/2023 -
Facility is cGMP operational for manufacturing of viral gene therapies, oncolytic viruses, and viral vaccines for clinical trials.
Porton Advanced, BRL Medicine Partner for Commercialization of Gene and Cell Therapies
18/09/2023 -
Alliance will enhance cell and gene therapy pipelines from BRL Medicine from clinical trials to further expedite commercialization of innovative therapies.
Otsuka, ShapeTX Collaborate on AAV Gene Therapies for Ocular Diseases
13/09/2023 -
Will apply Shape’s AAVid capsid discovery platform and transgene engineering technology with Otsuka’s expertise in genetic payload design and ophthalmology.
Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products
28/08/2023 -
This is the Draft Guidance for Industry, Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products
AGC Biologics Completes Expansion at Milan CGT Site
10/08/2023 -
Adds flexibility to support clinical to commercial stages for in–vivo end ex-vivo gene therapy applications.
Regeneron to Acquire Decibel Therapeutics
10/08/2023 -
Decibel’s lead investigational gene therapy DB-OTO is designed to provide hearing to people with otoferlin-related hearing loss.
Evox, Icahn School of Medicine Partner to Advance Next-Gen Gene Therapy
07/08/2023 -
Will work on developing exoAAV vectors as a novel gene delivery technology aimed at improving treatments for heart disease.
Alexion to Acquire Pfizer Gene Therapy Assets for up to $1B
03/08/2023 -
Portfolio includes preclinical gene therapy programs and enabling technologies with potential across several therapeutic areas.
Avantor to Expand Bridgewater, NJ Innovation Center
28/07/2023 -
New site will support customers' pipelines across all modalities, including monoclonals, cell and gene therapy and mRNA.
CSafe To Unveil First Frozen Active Temperature-Controlled Container
12/07/2023 -
Aims to address the rapid growth of mRNA vaccines and in preparation for the commercialization of cell and gene therapies.
OBiO Technology Adds Univercells Upstream Platform for Gene Therapy Mfg.
11/07/2023 -
Agreement combines the capacity and capabilities of OBiO process development scientists with enabling platforms and support from Univercells Technologies.
FDA Approves BioMarin's Roctavian for Severe Hemophilia A
11/07/2023 -
One-time, single-dose infusion is the first approved gene therapy for severe hemophilia A in the U.S.
Cytiva, BioCentriq Awarded NIIMBL Funding to Advance Gene Therapies
28/06/2023 -
Aims to develop new standards that can be used for AAV and advance the development and adoption of gene therapies.
bluebird bio’s BLA for lovo-cel Gets FDA Priority Review
23/06/2023 -
Lovo-cel is a one-time gene therapy specifically designed to treat the underlying cause of sickle cell disease.
Texcell Unveils State-of-the-Art Viral Clearance Testing Facility
16/06/2023 -
Will support biosafety studies for monoclonal antibodies, gene therapies, and medical devices coming to the market.
Astellas, KateTx Enter Exclusive License Agreement to Develop KT430
15/06/2023 -
Next-gen investigational gene therapy to treat X-linked myotubular myopathy (XLMTM), a life-threatening, rare neuromuscular disease.
Charles River Launches LVV Packaging Plasmids
15/06/2023 -
Aims to provide a streamlined solution to the challenges associated with plasmid sourcing in cell and gene therapies.
Charles River, INADcure Collaborate on Gene Therapy Manufacturing
15/06/2023 -
CDMO will perform HQ plasmid production in support of Phase I/II clinical trials for Infantile Neuroaxonal Dystrophy.
